These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

102 related items for PubMed ID: 7705964

  • 41. Functional reactivity of central cholinergic systems following desipramine treatments and sleep deprivation.
    Murugaiah KD, Ukponmwan OE.
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Oct; 368(4):294-300. PubMed ID: 13680087
    [Abstract] [Full Text] [Related]

  • 42. Potentiometric evaluation of solvent polymeric carbonate-selective membranes based on molecular tweezer-type neutral carriers.
    Lee HJ, Yoon IJ, Yoo CL, Pyun HJ, Cha GS, Nam H.
    Anal Chem; 2000 Oct 01; 72(19):4694-9. PubMed ID: 11028633
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Redistribution and enhanced urinary excretion of 2,2',4,4',5,5'-hexachlorobiphenyl (HCB) in rats using HCB-specific IgG and Fab fragments.
    Keyler DE, Goon DJ, Shelver WL, Ross CA, Nagasawa HT, St Peter JV, Pentel PR.
    Biochem Pharmacol; 1994 Aug 17; 48(4):767-73. PubMed ID: 8080450
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Overcoming the nephrotoxicity of radiometal-labeled immunoconjugates: improved cancer therapy administered to a nude mouse model in relation to the internal radiation dosimetry.
    Behr TM, Sharkey RM, Sgouros G, Blumenthal RD, Dunn RM, Kolbert K, Griffiths GL, Siegel JA, Becker WS, Goldenberg DM.
    Cancer; 1997 Dec 15; 80(12 Suppl):2591-610. PubMed ID: 9406714
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats.
    Li Q, Levy AD, Cabrera TM, Brownfield MS, Battaglia G, Van de Kar LD.
    Brain Res; 1993 Dec 10; 630(1-2):148-56. PubMed ID: 8118681
    [Abstract] [Full Text] [Related]

  • 53. Forced swim test-induced endocrine and immune changes in the rat: effect of subacute desipramine treatment.
    Connor TJ, Kelly JP, Leonard BE.
    Pharmacol Biochem Behav; 1998 Jan 10; 59(1):171-7. PubMed ID: 9443552
    [Abstract] [Full Text] [Related]

  • 54. UV-photodegradation of desipramine: Impact of concentration, pH and temperature on formation of products including their biodegradability and toxicity.
    Khaleel NDH, Mahmoud WMM, Olsson O, Kümmerer K.
    Sci Total Environ; 2016 Oct 01; 566-567():826-840. PubMed ID: 27254290
    [Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Renal tolerance of digoxin-specific Fab fragments in the rat.
    Advenier E, Mouajjah S, Bazin-Redureau M, Launay JM, Scherrmann JM.
    Toxicology; 1998 Apr 03; 126(3):223-9. PubMed ID: 9674970
    [Abstract] [Full Text] [Related]

  • 60. The nonlinear kinetics of desipramine and 2-hydroxydesipramine in plasma.
    Cooke RG, Warsh JJ, Stancer HC, Reed KL, Persad E.
    Clin Pharmacol Ther; 1984 Sep 03; 36(3):343-9. PubMed ID: 6467794
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.